A liquid-biopsy-based multicancer early detection test may detect early-stage disease and low DNA-shedding cancers

by

A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held April 14–19.

Leave A Comment

Your email address will not be published. Required fields are marked *